What's breaking now, across thousands of outlets.
An iterative, risk-based, model-driven digital validation strategy enables rapid responses to process changes and innovative technological implementations that would be slow to validate using traditional processes. The post Crossing the Digital Validation Chasm appeared first on GEN - Genetic Engineering and Biotechnology News .
We haven't written up this one. GEN Biotechnology has the full story — the link below goes straight to it.
A family of mutations seen in about 20% of human cancers drives malignancy by changing the accessibility of genes to a particular regulatory protein, according to a study by Weill Cornell Medicine…
Most microbes remain out of reach, and many antibiotic-producing genes stay silent. A new review argues that combining genomics, innovative cultivation, and scalable manufacturing could turn this…
Apertura says widening access to its TfR1 CapX capsid is a core philosophy, and that includes inviting a wide range of collaborations and supporting collaborators through advice and preclinical…
(MedPage Today) -- For patients with advanced or metastatic solid tumors who had initial responses to immune checkpoint inhibitors (ICIs), reducing dose intensity did not preserve efficacy, an interim…
Israel holds recruitment drive for British doctors amid physician brain drain Submitted by Katherine Hearst on Wed, 10/28/2026 - 12:55 Leaflets listing medical centres in illegal settlements were…
